Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Merck & Co. patents describe BTK inhibitors

July 19, 2016

EMA accepts for review MAA for adalimumab biosimilar SB-5

July 18, 2016

Merck & Co. patents BTK inhibitors

July 18, 2016

FDA advisory committee recommends approval of biosimilar etanercept

July 15, 2016

Merck & Co. patents BTK inhibitors

July 15, 2016

Urolithin A improves muscle function; Amazentis conducts clinical trial

July 14, 2016

Biocad's bispecific MAb shows promise for rheumatoid arthritis in preclinical studies

July 13, 2016

FDA confers orphan drug status to angiogenesis inhibitor nintedanib

July 12, 2016

Positive topline results from phase IIb trial of vobarilizumab as monotherapy in RA

July 8, 2016

FDA grants orphan drug designation for iBio-CFB03

July 7, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...